Skip to main content

and
  1. No Access

    Article

    Opportunities for Neuroprotective Drugs in the Era of Vascular Recanalization

    Zhifeng Qi, Ke Jian Liu in Translational Stroke Research (2024)

  2. No Access

    Article

    Baicalin Attenuates Blood-Brain Barrier Disruption and Hemorrhagic Transformation and Improves Neurological Outcome in Ischemic Stroke Rats with Delayed t-PA Treatment: Involvement of ONOO-MMP-9 Pathway

    Tissue plasminogen activator (t-PA) has a restrictive therapeutic window within 4.5 h after ischemic stroke with the risk of hemorrhagic transformation (HT) and neurotoxicity when it is used beyond the time wi...

    Hansen Chen, Binghe Guan, ** Chen, **ngmiao Chen in Translational Stroke Research (2018)

  3. No Access

    Article

    Normobaric Hyperoxia Extends Neuro- and Vaso-Protection of N-Acetylcysteine in Transient Focal Ischemia

    N-acetylcysteine (NAC), a precursor of glutathione that reduces reperfusion-induced injury, has been shown protection when it was administered pre-ischemia. However, less is known about t...

    Yushan Liu, Wen-Cao Liu, Yanyun Sun, **anzhi Shen, **aona Wang in Molecular Neurobiology (2017)

  4. Article

    Open Access

    Does normobaric hyperoxia increase oxidative stress in acute ischemic stroke? A critical review of the literature

    Stroke, one of the most debilitating cerebrovascular and nuerological diseases, is a serious life-threatening condition and a leading cause of long-term adult disability and brain damage, either directly or by...

    John Weaver, Ke Jian Liu in Medical Gas Research (2015)

  5. No Access

    Article

    Bcl-2 Phosphorylation Triggers Autophagy Switch and Reduces Mitochondrial Damage in Limb Remote Ischemic Conditioned Rats After Ischemic Stroke

    Autophagy, an important intracellular degradation pathway, has been reported to clear impaired mitochondria and reduce mitochondria-mediated injury in ischemic disease. Our study and other recent investigation...

    Zhifeng Qi, Wen Dong, Wenjuan Shi, Rongliang Wang in Translational Stroke Research (2015)

  6. Article

    Open Access

    Extended normobaric hyperoxia therapy yields greater neuroprotection for focal transient ischemia-reperfusion in rats

    Normobaric hyperoxia (NBO) therapy is neuroprotective in acute ischemic stroke. However, how long the NBO should last to obtain optimal outcome is still unclear. Reports show that ischemic penumbra blood suppl...

    Zhongrui Yuan, Rong Pan, Wenlan Liu, Ke Jian Liu in Medical Gas Research (2014)

  7. No Access

    Article

    AKT-Related Autophagy Contributes to the Neuroprotective Efficacy of Hydroxysafflor Yellow A against Ischemic Stroke in Rats

    Hydroxysafflor yellow A (HSYA) has been approved clinically for treating cardiac patients in China since 2005. Recent studies have indicated that HSYA may be neuroprotective at 24 h in experimental stroke mode...

    Zhifeng Qi, Feng Yan, Wenjuan Shi, Chencheng Zhang in Translational Stroke Research (2014)

  8. Article

    Open Access

    Normobaric hyperoxia-based neuroprotective therapies in ischemic stroke

    Stroke is a leading cause of death and disability due to disturbance of blood supply to the brain. As brain is highly sensitive to hypoxia, insufficient oxygen supply is a critical event contributing to ischem...

    Zhifeng Qi, Wenlan Liu, Yumin Luo, Xunming Ji, Ke Jian Liu in Medical Gas Research (2013)

  9. Article

    Open Access

    Normobaric hyperoxia protects the blood brain barrier through inhibiting Nox2 containing NADPH oxidase in ischemic stroke

    Normobaric hyperoxia (NBO) has been shown to be neuro- and vaso-protective during ischemic stroke. However, the underlying mechanisms remain to be fully elucidated. Activation of NADPH oxidase critically contr...

    Wenlan Liu, Qingquan Chen, Jie Liu, Ke Jian Liu in Medical Gas Research (2011)